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PURPOSE. To estimate visual field (VF) sensitivity at which retinal nerve fiber layer (RNFL)
thinning reaches the measurement floor and at which RNFL stops thinning (change points),
the dynamic range of RNFL thickness, and the number of steps from normal to RNFL floor
among three optical coherence tomography (OCT) devices.
METHODS. Glaucomatous patients (n ¼ 58) and healthy subjects (n ¼ 55–60) prospectively
underwent VF testing and RNFL thickness measurement with Cirrus, Spectralis, and RTVue.
Change points and corresponding RNFL thicknesses were estimated with simple linear
regression (SLR) and Bayesian change point (BCP) analyses. The dynamic range and number
of steps to RNFL floor were determined.
RESULTS. The average VF change points and corresponding residual thickness at the time RNFL
stopped thinning were 22.2 dB and 57.0 lm (Cirrus), 25.3 dB and 49.2 lm (Spectralis),
and 24.6 dB and 64.7 lm (RTVue). The RNFL dynamic ranges derived from SLR values were
wider on Spectralis (52.6 lm) than on Cirrus (35.4 lm) and RTVue (35.5 lm); the
corresponding number of steps to reach the RNFL floor were 9.0 on Cirrus, 10.6 on
Spectralis, and 8.3 on RTVue.
CONCLUSIONS. The relative VF sensitivity at which average RNFL thickness reaches the
measurement floor, the residual layer thickness, and RNFL dynamic measurement range differ
among the three devices. However, the number of steps from normal to the RNFL thickness
floor is comparable.
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Assessments of retinal nerve fiber layer (RNFL) and opticnerve head via optical coherence tomography (OCT) and
visual field (VF) using standard automated perimetry (SAP) are
often used for the diagnosis and management of glaucoma.
Performing both tests in patients suspected of having glaucoma
or those with definite glaucoma stems from the fact that the
disease results in both structural changes affecting inner retinal
layers and peripheral VF deficits that may lead to blindness if
the disease is left untreated. The assessment of glaucoma-
induced structural and functional damage has improved
tremendously over the years, which in turn has enhanced the
ability to detect and monitor glaucoma. However, this
improvement has not translated into a complete understanding
of the nature of the relationship between structural damage and
functional loss during the course of the disease. Indeed, while it
has been established that there is a good relationship between
the two components, the natural history of the structure–
function relationship in glaucoma has not been completely
elucidated. For example, it is still debated whether this
relationship is linear or nonlinear.1–8 Interindividual variability
(i.e., some patients show structural changes prior to detectable
VF abnormalities while others experience the converse), the
difference in structural parameter measurements (i.e., RNFL)
obtained with different OCT devices, the type of VF informa-
tion used (i.e., full sensitivity thresholds, total deviation
sensitivities, mean deviation, VF index), and the type of map
used for spatial relationship between structural and functional
measures are among the factors that may account for
discrepancies among studies and the difficulty in better
understanding the structure–function relationship in glaucoma.
Additional challenges include differences in the dynamic range
and the floor of structural measures across devices.
The concept of floor and dynamic range of structural
parameters in glaucoma has gained attention recently as a result
of improvements in imaging and measuring inner retinal layers
and optic nerve head (ONH) structures. Since the first mention
of floor of RNFL thickness determined from measurements
obtained in glaucomatous eyes with scanning laser polarimetry
by Blumenthal et al.,9 a few other investigators have reported
on the same topic using either time-domain OCT10 or spectral-
domain OCT (SDOCT).11–13 Conceptually, the floor and
dynamic range of RNFL thickness are interrelated. Studying
both simultaneously may not only improve our understanding
of the structure–function relationship but also will provide
clinically useful information with regard to glaucoma follow-up.
The purpose of the current study was to estimate and compare
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the floor and dynamic range of RNFL thickness measured with
three different SDOCT devices in patients with glaucoma and
to assess the structure–function relationship globally and
focally in each case.
SUBJECTS AND METHODS
Subjects
Following approval of the study protocol by Biomedical
Institutional Review Boards of the University of North Carolina
at Chapel Hill and the University of Miami, patients 18 years or
older with documented moderate to severe primary open-
angle glaucoma (POAG) or normal-tension glaucoma (NTG)
were consecutively recruited and enrolled in the study in
compliance with the tenets of the Declaration of Helsinki.
Glaucoma was diagnosed following a complete ophthalmic
examination that included fundus ophthalmoscopy, goniosco-
py, applanation tonometry, optic disc stereophotography, and
VF testing with SAP (24-2 Swedish Interactive Threshold
Algorithm program using the Humphrey Visual Field Analyzer
[Carl Zeiss Meditec, Inc., Dublin, CA, USA]). Glaucoma was
defined based on characteristic glaucomatous ONH damage
and typical glaucomatous VF loss (defined as glaucoma
hemifield test results outside normal limits, a pattern standard
deviation with a P value < 5%, or a cluster of three or more
points in the pattern deviation plots in the superior or inferior
hemifield with P values < 5%, one of which had to have a P <
1%) in eyes with open iridocorneal angles. Moderate and
severe glaucomas were defined using the Hodapp-Anderson-
Parrish severity scale.14 Exclusion criteria for the study were a
history of or current retinal disease, nonglaucomatous optic
neuropathy, neurologic disease, treatments that may cause
optic neuropathy, and a history of intraocular surgery except
for glaucoma and cataract surgery performed more than 3
months prior to enrollment.
Data from age-matched normal subjects who participated in
the Cirrus HD-OCT (Carl Zeiss Meditec, Inc.) and RTVue
(Optovue, Inc., Fremont, CA, USA) were also used. In addition,
the Spectralis OCT (Heidelberg Engineering, Heidelberg,
Germany) RNFL data of normal subjects used for this analysis
were provided by the investigators of the National Eye
Institute–sponsored Diagnostic Innovations in Glaucoma Study
conducted at the University of California-San Diego, San Diego,
California (UCSD). Exclusion criteria for normal subjects
included IOP ‡ 22 mm Hg or history of elevated IOP; any
type of glaucoma in either eye; intraocular surgery in the study
eye (except uncomplicated cataract or refractive surgery
performed more than 3 months prior to enrolment); best-
corrected visual acuity worse than 20/40; evidence of diabetic
retinopathy, macular edema, or other vitreoretinal disease; or
evidence of optic nerve abnormality in either eye. Subjects
with cup-to-disc ratio (CDR) asymmetry ‡ 0.2 or an abnormal
VF indicated by a pattern standard deviation (PSD) outside 95%
confidence limits or a glaucoma hemifield test (GHT) result
outside normal limits were also excluded.
RNFL Thickness Measurement
All patients underwent RNFL thickness measurement with Cirrus
HD-OCT, Spectralis OCT, and RTVue during the same session.
The peripapillary circular sampling pattern (3.4-mm circle
centered on the optic disc) was used on each instrument for
RNFL thickness measurements. Only high-quality scans defined
as those with good quality score (signal strength ‡ 6 for Cirrus,
quality score ‡ 20 for Spectralis, and signal strength index ‡ 30
for RTVue) and without segmentation failure and no eye
movement or blinking artifacts were retained for analysis. The
overall average RNFL and averages of the superior and inferior
quadrant RNFL thicknesses were used for analysis in this study.
Visual Field Data Handling
Only reliable VFs (33% false positives or false negatives, and
15% fixation losses) were used in this study. The analyses in
this study used all 52 relative sensitivity values (expressed in
dB) from the total deviation numerical plot. For spatial
correlation between quadrant RNFL and corresponding VF
sectors, we used a VF map with four VF sectors (superior and
inferior: 21 test data points each) as we recently described,15
but only the superior and inferior field sectors were considered
for analysis. For each field sector, the relative sensitivity was
obtained by averaging all the sector’s data point relative
sensitivities. The averaging was performed after the total
deviation values were antilogged as previously described by
Hood and Kardon.6 The global relative sensitivity was the
average of all 52 data point sensitivities. Left eye data were
converted to right eye format for consistency.
RNFL Residual Estimation
The residual thickness was determined using two methods that
estimated the change point, which is the relative retinal
sensitivity at which the RNFL stops getting measurably thinner,
and the corresponding residual thickness. The first method, a
Bayesian change point (BCP) analysis, is derived from the Hood
and Kardon model6 that we modified and fit in the Bayesian
setting.16 The purpose of the modification was to model the
data for RNFL thickness to flatten out from a certain value of
relative VF sensitivity, so that RNFL measurements will stop
getting thinner despite continuous VF loss. Details about this
model have been described elsewhere.15 The second method,
a simple linear regression change point (SLRCP) analysis, is a
derivation of the tipping point of the relationship between
RNFL thickness and visual function described by Wollstein et
al.17 In this method we used simple linear regression lines of
the relationship between RNFL thickness and relative VF
sensitivity. First, a series of regression line pairs were plotted,
one in the steep and another in the plateau portion of the
relationship, which allowed for the determination of the
location of the change in slope steepness. Finally, the pairs of
regression lines were compared in terms of slope, and the pair
with the most pronounced slope in the steep portion and the
least slope in the plateau portion of the relationship was
considered as best fitting the data. Fourth, the intersection
between the two regression lines was identified as the change
point, which allowed easy determination of its corresponding
coordinate on the relative VF sensitivity axis. In both methods
(BCP and SLRCP), knowing the change point allowed the
determination of post–change point residual layer thickness
and its corresponding relative VF sensitivity.
Due to the interindividual variability in residual thickness
and change points, we calculated the post–change point
residual layer thickness and corresponding relative VF sensi-
tivity by averaging all RNFL thicknesses with VF sensitivity
equal to or worse than the change point globally and for each
sector. The post–change point residual layer thickness and
relative VF sensitivity were considered as the measured
residual thickness and relative VF sensitivity, respectively.
Student’s t-tests were used to compare mean post–change
point residual layer thicknesses with corresponding relative VF
sensitivities obtained from the two methods globally and
sectorally on each OCT device. Values from the three devices
were compared using ANOVA. A P value < 0.05 was
considered statistically significant.
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RNFL Dynamic Range Determination
The dynamic range of global and sectoral RNFL was
determined for each OCT device by subtracting the average
residual layer thickness of glaucoma patients from the average
RNFL thickness of normal subjects. For comparison purposes,
the dynamic range was calculated using the BCP, SLRCP, post-
BCP, and post-SLRCP residuals. Knowing the test–retest
variability (TRTV) of RNFL thickness measured with OCT, it
is possible to determine for each device the average number of
steps between normal RNFL thickness and the RNFL floor. This
information is important to know because the greater the
number of steps, the more opportunities there are to detect a
significant change and the longer a glaucomatous patient can
be followed until the RNFL reaches the floor either globally or
for a given RNFL sector. The number of steps was determined
by dividing the RNFL dynamic range by the tolerance limit of
intervisit TRTV in glaucoma patients. In this study, we used
tolerance limits of TRTV of 3.9 lm for Cirrus HD-OCT,18 4.95
lm for Spectralis,19 and 4.3 lm for RTVue.20
RESULTS
Participant General Characteristics
As shown in Table 1, the patients (n ¼ 58, mean age 65.4 6
14.7 years, visual field mean deviation [VFMD]18.7 6 8.2 dB)
included 15 with moderate and 43 with severe glaucoma. The
normal subjects were distributed as follows: 60 in the
Spectralis group (mean age 64.5 6 10.6 years, VFMD 0.06
6 0.9 dB), 55 in the RTVue group (mean age 64.8 6 10.7
years, VFMD 0.04 6 1.03 dB), and 60 in the Cirrus group
(mean age 66.9 6 17.9 years, VFMD 0.24 6 1.1 dB). The
patients had a significantly worse VFMD and relative VF
sensitivities and thinner RNFL parameters than the controls (all
P < 0.001), but the two groups were comparable in age (P >
0.05). All RNFL parameters and relative VF sensitivities were
thinner in glaucoma patients compared to normal subjects (all
P < 0.001).
RNFL Floor
The results of the BCP and SLR analyses are shown in Table 2.
Estimates for global residual layer from the BCP method, which
indicates the thickness of the residual layer when the RNFL
stops thinning, were 57.0 6 1.3 lm on Cirrus, 49.2 6 1.6 lm
on Spectralis, and 64.7 6 1.4 lm on RTVue (Table 2; Fig. 1, top
row). The residual layers of the superior and inferior quadrants
were thicker than the global residual thickness on all three
devices. The global change point estimated from the BCP
analysis was similar between devices (22.2 6 6.4 dB on
Cirrus, 25.3 6 4.8 dB on Spectralis, and 24.6 6 5.2 dB on
RTVue). The SLR method estimated the global change point and
corresponding RNFL thickness, respectively, at 10.4 dB and
TABLE 1. Study Participants’ Demographic and Clinical Characteristics
Cirrus Spectralis RTVue
Normal Glaucoma P Normal Glaucoma P Normal Glaucoma P
Age, y 66.9 6 17.9 65.4 6 14.7 0.099 64.9 6 7.0 65.4 6 14.7 0.099 64.8 6 10.7 65.4 6 14.7 0.55
Visual field MD, dB 0.2 6 1.1 18.7 6 8.2 <0.001 0.06 6 0.9 18.7 6 8.2 <0.001 0.04 6 1.0 18.7 6 8.2 <0.001
Total deviation loss, dB
Global 0.3 6 0.9 16.9 6 8.1 <0.001 0.04 6 1.1 16.9 6 8.1 <0.001 0.07 6 1.0 16.9 6 8.1 <0.001
Superior field 0.2 6 1.3 19.2 6 9.9 <0.001 0.05 6 1.2 19.2 6 9.9 <0.001 0.03 6 1.3 19.2 6 9.9 <0.001
Inferior field 0.2 6 1.1 19.8 6 9.7 <0.001 0.08 6 1.0 19.8 6 9.7 <0.001 0.09 6 1.1 19.8 6 9.7 <0.001
RNFL thickness, lm
Global 93.7 6 9.7 58.8 6 7.2 <0.001 100.9 6 8.9 51.3 6 12.9 <0.001 99.4 6 9.2 67.0 6 10.4 <0.001
Superior quadrant 119.4 6 17.3 66.7 6 11.5 <0.001 119.4 6 14.2 58.9 6 17.7 <0.001 122.2 6 14.2 79.5 6 14.5 <0.001
Inferior quadrant 122.2 6 16.9 63.0 6 13.7 <0.001 134.0 6 17.7 60.2 6 21.5 <0.001 122.9 6 13.9 80.0 6 17.0 <0.001
SD, standard deviation.
TABLE 2. Bayesian Change Point and Simple Linear Regression Change Point Estimates and Corresponding Retinal Nerve Fiber Layer (RNFL) Floor
Bayesian Change Point Simple Linear Regression
RNFL Floor, lm VF Sensitivity, dB RNFL Floor, lm VF Sensitivity, dB
Cirrus
Global 57.0 6 1.3 (54.5; 59.6) 22.2 6 6.4 (32.4; 10.6) 57.3 6 1.2 (54.9; 59.7) 10.4 6 3.6 (17.5; 3.3)
Superior quadrant 65.0 6 2.4 (60.4; 69.7) 22.2 6 6.5 (32.3; 9.6) 64.9 6 2.4 (60.2; 69.6) 13.9 6 4.9 (23.5; 4.3)
Inferior quadrant 61.2 6 2.3 (56.8; 65.8) 21.1 6 7.7 (32.9; 7.7) 65.5 6 2.2 (61.2; 69.8) 12.6 6 4.1 (20.6; 4.6)
Spectralis
Global 49.2 6 1.6 (46.0; 52.3) 25.3 6 4.8 (32.6; 15.7) 48.3 6 1.5 (45.4; 51.2) 14.0 6 4.7 (23.2; 4.8)
Superior quadrant 57.8 6 2.6 (52.6; 62.9) 23.7 6 5.7 (32.4; 12.4) 58.3 6 2.7 (53.0; 63.6) 13.2 6 4.0 (21.0; 5.4)
Inferior quadrant 60.1 6 2.9 (54.5; 66.0) 23.7 6 6.1 (33.1; 11.5) 62.9 6 2.6 (57.8; 68.0) 13.4 6 4.6 (22.4; 4.4)
RTVue
Global 64.7 6 1.4 (62.1; 67.4) 24.6 6 5.2 (32.5; 14.4) 63.9 6 1.3 (61.4; 66.5) 14.4 6 4.7 (23.6; 5.2)
Superior quadrant 76.7 6 2.2 (72.3; 80.9) 22.6 6 6.3 (32.3; 10.2) 78.9 6 2.3 (74.4; 83.4) 11.3 6 5.9 (22.9; 0.3)
Inferior quadrant 78.0 6 2.4 (73.5; 82.8) 19.3 6 8.4 (32.8; 6.0) 84.4 6 1.9 (80.7; 88.1) 11.7 6 5.4 (22.3; 1.1)
Values in parentheses indicate lower and upper 95% confidence intervals.
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57.3 lm for Cirrus, 14.0 dB and 49.2 lm for Spectralis, and
14.4 dB and 64.7 lm for RTVue (Fig. 1, bottom row). The
RNFL in the superior and inferior quadrants on the three
devices stopped thinning at relative VF sensitivities between
19.3 dB and23.7 dB after reaching the floor earlier at relative
VF sensitivities ranging between 11.3 dB and 14.4 dB.
Residual layer thickness estimates by both methods from RTVue
tended to be thicker than those from Cirrus and Spectralis.
The global post-BCP residual layer was similar for Cirrus and
RTVue (57.6 6 5.0 vs. 58.4 6 4.6 lm, P ¼ 0.95), but
significantly thicker than that measured with Spectralis (48.0
6 7.7 lm, P < 0.001) (Table 3). Post-BCP residuals in the
superior and inferior quadrants did not differ on each device,
but significantly differed among devices (all P < 0.01).
Similarly, the post-SLRCP residuals for global and superior
and inferior quadrants were thicker than residuals in the nasal
FIGURE 1. Bayesian change point plots (top row) and simple linear regression plots (bottom row) of the structure–function relationship of average
RNFL thickness measured with Cirrus (A), Spectralis (B), and RTVue (C) with SAP average relative VF sensitivity. On simple linear regression plots,
the meeting point between the two regression lines provides the coordinates of the amount of VF loss and corresponding residual layer thickness.





PResidual, lm Residual, lm VF Loss, dB VF Loss, dB
Cirrus
Global 57.6 6 5.0 (54.8; 60.5) 57.1 6 6.5 (55.2; 59.1) 0.79 28.4 6 3.7 (30.5; 26.2) 20.0 6 7.0 (22.2; 17.9) <0.01
Superior quadrant 63.5 6 8.4 (60.2; 66.8) 63.3 6 8.4 (60.4; 66.1) 0.91 28.3 6 3.4 (29.6; 27.0) 25.7 6 5.3 (27.7; 24.3) 0.03
Inferior quadrant 59.8 6 12.9 (54.7; 64.9) 61.8 6 14.0 (57.3; 66.4) 0.55 29.2 6 3.9 (30.7; 27.6) 25.1 6 7.0 (27.4; 22.9) <0.01
Spectralis
Global 48.0 6 7.7 (42.5; 53.5) 44.1 6 9.3 (41.2; 47.6) 0.51 30.3 6 2.2 (31.9; 28.7) 23.0 6 5.8 (24.6; 20.3) <0.01
Superior quadrant 53.2 6 16.4 (45.9; 60.4) 53.4 6 14.3 (48.4; 58.0) 0.95 29.1 6 2.9 (30.4; 27.9) 25.7 6 5.3 (27.5; 24.0) <0.01
Inferior quadrant 53.8 6 23.4 (43.7; 63.9) 56.8 6 21.5 (49.7; 64.0) 0.88 30.3 6 2.9 (31.6; 29.1) 25.8 6 6.6 (28.0; 23.6) <0.01
RTVue
Global 58.4 6 4.6 (55.3; 61.4) 61.2 6 5.6 (58.2; 63.5) 0.14 29.8 6 2.6 (31.6; 28.0) 23.3 6 5.7 (28.0; 23.8) <0.01
Superior quadrant 74.8 6 9.0 (71.3; 78.4) 75.6 6 9.6 (71.9; 78.6) 0.74 28.3 6 3.4 (29.6; 27.0) 24.3 6 6.4 (29.2; 26.4) <0.01
Inferior quadrant 76.0 6 17.5 (69.2; 82.7) 78.9 6 18.6 (69.6; 81.9) 0.52 28.8 6 4.2 (30.5; 27.2) 24.5 6 7.4 (25.7; 22.1) <0.01
Values in parentheses indicate lower and upper 95% confidence intervals.
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and temporal quadrants on all three devices (Table 3). No
significant differences were found between post-BCP and post-
SLRCP residual layer thicknesses on any of the devices (all P >
0.05). In contrast, corresponding post-BCP relative VF sensi-
tivities (range,29.2 to28.3 dB for Cirrus,30.3 to29.1 dB
for Spectralis, and 29.8 to 28.3 dB for RTVue) were
significantly lower than post-SLRCP sensitivities (range, 25.7
to 20.0 dB on Cirrus, 25.8 to 23.0 dB for Spectralis, and
24.5 to 23.3 dB for RTVue) (all P < 0.05).
RNFL Dynamic Range and Number of Steps to
RNFL Floor
The dynamic range for global and sectoral RNFL on the three
OCT devices, estimated using both the residual layer thickness
obtained at the time RNFL thinning first reaches the floor and
the average of all RNFL thicknesses with VF sensitivity equal to
or worse than the SLR change, is listed in Table 4. The global
RNFL dynamic range on Spectralis (52.6 lm) was wider than on
Cirrus (35.4 lm) and RTVue (35.5 lm). Spectralis also showed
wider dynamic ranges for the superior and inferior quadrant
RNFL compared to Cirrus and RTVue, as did Cirrus relative to
RTVue. The number of steps from normal global RNFL thickness
to the floor was 9.0 on Cirrus, 10.6 on Spectralis, and 8.3 on
RTVue (Table 4; Fig. 2). Cirrus and Spectralis also had a similar
number of steps for superior and inferior quadrant RNFL, which
were greater than the step counts on RTVue.
DISCUSSION
Regardless of the primary risk factor, there is a general
consensus that glaucoma is a slowly progressive neurode-
generative disease associated with death of retinal ganglion
cells and degeneration of their axons. Structurally, this is
manifested, among other things, by progressive RNFL
thinning until the floor is reached if the disease is left
untreated or not adequately treated. Although past studies
have described the course of RNFL thinning prior to
reaching the floor,6,12,13,21 one unaddressed question has
been whether the floor corresponds to the end of the
thinning process. With the availability of several SDOCT
platforms currently used in the clinical setting, it also has
largely remained unclear how these platforms compare to
each other with regard to RNFL floor and dynamic range. In
this study, we used two statistical methods to estimate the
amounts of relative VF sensitivity at which RNFL thinning
reaches the floor and at which RNFL thinning subsequently
stops (change points), the dynamic range of RNFL thickness,
and the number of steps from normal RNFL to RNFL floor.
The values were compared among three SDOCT platforms.
TABLE 4. RNFL Dynamic Range and Number of Steps From Normal
RNFL to the Floor
Dynamic Range, lm Number of Steps
SLRCP Post-SLRCP SLRCP Post-SLRCP
Cirrus
Global 35.4 36.6 9.0 9.4
Superior quadrant 54.5 56.1 7.8 8.0
Inferior quadrant 56.7 60.4 8.6 9.2
Spectralis
Global 52.6 56.8 10.6 11.5
Superior quadrant 61.1 66.0 7.6 8.3
Inferior quadrant 71.1 76.9 9.2 9.9
RTVue
Global 35.5 38.2 8.3 8.9
Superior quadrant 43.3 46.6 4.5 4.9
Inferior quadrant 38.5 44.0 4.8 5.4
FIGURE 2. Staircase representation of the number of steps from normal
average RNFL thickness to average RNFL floor on Cirrus, Spectralis, and
RTVue. The upper and lower dashed lines indicate the values of
normal RNFL thickness and floor, respectively; the space between
them is the dynamic range. The height of the steps on each plot
represents the TRTV. The patterned area represents the residual layer
thickness. The straight line connecting the stairs in the Cirrus plot
indicates that RNFL actually thins continuously rather than in steps.
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Our results indicate that (1) RNFL thinning reaches the floor
at relative VF sensitivity greater than when the thinning
ends, without significant differences in their corresponding
residual layer thicknesses; (2) the measured thicknesses at
the time RNFL reaches the floor and when the thinning
process ends differed among the three OCT platforms, and
(3) the dynamic range of RNFL also varied among the
devices, whereas the number of steps from normal RNFL to
RNFL floor did not vary much among them. These findings
have significant clinical implications for the use of OCT and
VF to monitor glaucoma patients.
The reason RNFL measurements do not go all the way to
zero in glaucoma has been well documented histologically; its
architectural support, made of the retinal glial cells (Müller
cells, astroglia, microglia) and vessels, does not degenerate
concurrently with the retinal ganglion cell axons. Quigley and
Addicks22 showed in primates that RNFL damage with total
loss of axons following experimental lesions to the optic nerve
leaves a mixture of capillaries, astrocytes, and Müller cells,
with significant variations in the ratio of axons to supportive
tissue at different locations. In addition, it has been shown that,
as a response to progressive glaucomatous axonal loss, the
RNFL layer may undergo remodeling, including glial cell
proliferation.23,24
Linear models of the relationship between cross-sectional
SDOCT RNFL and SAP data have indicated that RNFL layer
thickness measurements reach the lower end of their dynamic
range while there is still remaining function.13,25 This is
corroborated by our findings that average RNFL thickness
measured with Cirrus, Spectralis, and RTVue reached the floor
at relative VF sensitivities of 10.4, 14.0, and 14.4 dB,
respectively. In other words, since the relative VF sensitivity
ranges between 0 dB (no loss corresponding to low-contrast
stimulus, i.e., in healthy subjects) and approximately 35 dB
(complete loss corresponding to high-contrast stimulus), 70.3%,
60.3%, and 58.9% of global function still remained at the time
RNFL reached the measured floor. The average residual layer
thicknesses were 61.2% (Cirrus), 47.9% (Spectralis), and 64.3%
(RTVue) of healthy subject values. The clinical relevance of this
finding is the potential for monitoring patients using functional
tests after structural measures have reached the floor. Kanamori
et al.26 studied the relationship of VF sensitivity with RNFL
thickness measured with Cirrus, RTVue, and three-dimensional
OCT 2000 (Topcon, Inc., Tokyo, Japan) using the Hood and
Kardon linear model. They reported average residual layer
thicknesses of 60.6, 69.7, and 64.7 lm, respectively, which
represented 64.6%, 68.3%, and 61.5% of RNFL thickness of the
controls. They did not mention the corresponding sensitivity
losses. As has been shown previously by others,7,27–30 our
results also suggest that the structure–function relationship in
glaucoma varies over time so that structural measures are more
sensitive in early stages, whereas functional measures provide
more information in advanced disease. Rather than VF being
spared in early stages of the disease, this differential behavior
between structural and functional measures in glaucoma may
be due to SAP inability to detect small functional loss, as a result
of the redundancy of the visual system and the overlap of
receptive fields. Interestingly, other functional tests such as
short-wavelength automated perimetry, flicker perimetry, high-
pass resolution perimetry, frequency doubling technology
perimetry, and pattern electroretinogram have demonstrated
the ability to detect glaucomatous functional damage earlier
than achromatic perimetry.31–37
In the present study, the residual layer thicknesses in the
superior and inferior quadrants were, respectively, 54.4% and
53.6% (Cirrus), 48.8% and 46.9% (Spectralis), and 64.6% and
68.7% (RTVue) relative to controls, indicating thicker residuals
on RTVue compared to Cirrus and Spectralis. In a recent
retrospective study, we also reported that residual thicknesses
on Spectralis were 47.5% and 45.4% relative to controls in the
superior and inferior quadrants, respectively, compared to
70.7% and 62.7% for RTVue.15 An analysis of RTVue RNFL data
from the Diagnostic Innovation in Glaucoma Study (DIGS) and
African Descent and Glaucoma Evaluation Study (ADAGES)
using the Hood and Kardon linear model found a residual of
83.3 lm or 60% of normal RNFL thickness in the inferotemporal
sector and 80.7 lm or 61% of normal RNFL thickness.13 A
subsequent study by the same investigators using Cirrus RNFL
data reported residual thicknesses of 61.2 lm (46% of normal
RNFL) in the inferotemporal and 60.4 lm (49% of normal RNFL)
in the superotemporal region.25 In contrast, application of the
same analytical model to Spectralis and SAP data from 27
healthy eyes and 68 eyes with early to advanced glaucoma
estimated a greater residual layer thickness in the inferotempo-
ral (54.3 lm) than in the superotemporal sector (80.8 lm).38
While the interdevice difference in absolute residual layer
thickness we found has to be ascribed mostly to the difference
in segmentation algorithms, the discrepancies across studies
using the same device is likely influenced by the anatomical
differences in study populations, the use of different structure–
function relationship mapping schemes, and statistical methods.
We recently reported on estimates of the amount of relative
VF sensitivity and corresponding residual layer thickness at the
time RNFL measured with Spectralis and RTVue stops thinning
in glaucoma.15 That study, performed retrospectively and in
different subjects for each device, as well as the current study,
performed prospectively and using the same glaucoma subjects
across all the devices, show that RNFL thinning stops in the
late stage of the disease. Thus, RNFL thinning progresses after
reaching the floor, but the slope is not significant as
demonstrated by the lack of difference between residual layer
thicknesses at the time the RNFL reaches the floor and when it
stops thinning. Likewise, Hood et al.11 found a weak and
nonsignificant thinning of the residual thickness over time
from the last episode of anterior ischemic optic neuropathy.
Putting this information in the context of the dynamic range of
structural and functional measures, our findings confirm the
observation that RNFL thickness has a shorter dynamic range
than VF measures as determined by SAP. Thus, the short
dynamic range of RNFL is a limiting factor for exploring and
describing the structure–function relationship in glaucoma
once relative VF sensitivity becomes lower than10 dB and the
RNFL thickness is approximately 50 to 55 lm for Cirrus and
Spectralis and 65 lm for RTVue. Unlike VF assessment, the
dynamic range of RNFL thickness cannot be expanded once it
reaches the floor. As for VF, the Humphrey Field Analyzer 24-2
program with a size III stimulus is the most commonly used
testing mode. The mean deviation (MD) or VF index (VFI) can
help stage the disease, with the difference between the two
being that other causes than glaucoma may reduce the MD. In
contrast, the VFI measures visual function loss caused by
glaucomatous damage only, and its dynamic range varies
between 100% (full field) and 0% (complete field loss). When
VF seems to be completely lost through the 24-2 test pattern
and size III stimulus, the dynamic range of the VF can be
increased by switching to a size V stimulus, allowing function
to still be monitored after the dynamic range of the RNFL has
reached the lower end. With further field loss, more dynamic
range expansion is possible using the 10-2 test with a size V
stimulus and 28 grid points spacing, which allows crowding of
a greater number of testing points in a small area.39
The concept of numbering steps from normal RNFL to the
RNFL floor is a useful clinical parameter that is complementary
to the RNFL dynamic range. It may represent another objective
way of monitoring and staging the disease, as it indicates where
the patient stands on the RNFL thickness ‘‘stairway’’ from
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normal RNFL to its floor. We have found that despite some
differences in dynamic range, the three OCT platforms were in
fact comparable with regard to the number of steps from
normal RNFL to the floor. The number of steps for average
RNFL thickness was 9.0 on Cirrus, 10.6 on Spectralis, and 8.3
on RTVue. These figures are based on current TRTV for each
device. It remains unclear whether these numbers are
expected to increase as a result of further improvement in
the future with regard to segmentation algorithm, increase in
axial resolution, and decrease in TRTV. It should be noted that
a caveat to this concept of steps is that in the real world the
RNFL does not thin in a series of steps but rather in a
continuous manner, as illustrated by the straight line connect-
ing the steps in Figure 2 (top). It could also be argued that
because the number of steps to the RNFL floor is a function of
the RNFL TRTV, which in turn may considerably differ across
studies, the most appropriate design would have been to
measure RNFL thickness in the same group of subjects with the
three OCT devices and to calculate the RNFL TRTVs. While
future studies are needed using this design, it is likely that the
TRTVs may remain different because the three devices are
known to generate different RNFL thickness values.
Prior studies based on the Hood and Kardon model have
estimated the residual layer thickness by averaging the RNFL
thicknesses of all subjects with relative VF sensitivity worse
than10 dB.6,12,13,21,25,38 This cutoff value was estimated to
be the asymptotic point and was determined by simple
visual inspection of the curve of the relationship between
RNFL and SAP. While the SLR method used herein roughly
agreed with Hood and Kardon’s predictions with regard to
the asymptotic point, it also showed that the asymptotic
point may be variable, which confirms our recent findings.15
Interestingly, the predicted residual thicknesses by the SLR
method were comparable to thicknesses obtained by
averaging all residual layers in subjects with relative VF
sensitivities equal to or worse than the asymptotic points.
The corollary to this finding is that the SLR method was
accurate in predicting the value of the residual layer
thickness, and it represents a reliable alternative to the
averaging method.
Some important aspects should be considered when
interpreting our findings or attempting to apply them to
individual patients or other population groups. First, one
should keep in mind the cross-sectional nature of the data, so
that the results may differ from those obtained if longitudinal
data are used. Glaucoma is a slowly progressing disease, and
thus determining longitudinally when RNFL thinning reaches
the floor or when RNFL stops completely thinning requires
decades of follow-up. Because this has not been possible so
far, studies determining the trend of the structure–function
relationship in glaucoma over time have, as in the present
study, alternatively relied on mathematical or statistical
models using cross-sectional data across all severity stages
of the disease.13,21,25,29 Interestingly, RNFL thickness values
derived from the BCP model were lower, although not
significantly, than those from the SLR model, suggesting that
reaching the floor may not correspond to the end of the
thinning process. Second, our results may have been
influenced by the effect of age on RNFL thinning,40 residual
thickness,11 and VF sensitivity reduction.41 In order to
minimize these effects, we used VF total deviation values,
which are age corrected, and we age matched normal and
glaucoma subjects. Third, the large variability in the number
of retinal ganglion cell axons and thus in RNFL thickness
across the normal population implies that the results may
differ from one study population to another. Fourth, a
compromise is yet to be found on which estimation or
analytical model better characterizes the correlation between
structural and functional loss in glaucoma; interestingly the
models used in the present study generated results that are
comparable to those of previous studies despite differing
statistical methods. Fifth, multiple SDOCT devices by
different manufacturers are currently available for clinical
use. The lack of standardization with regard to optical
properties, axial resolution, scanning speed, light source
characteristics, segmentation algorithm, and image process-
ing capabilities has resulted in systematic measurement
differences among different OCT platforms.42,43 From a
practical standpoint, such differences prevent longitudinal
monitoring of patients’ OCTs from different manufacturers;
they also prevent the comparison of OCT data during
multicenter clinical trials if participating centers use different
OCT platforms. One way of circumventing this challenge is to
normalize OCT data from different OCTs. Therefore, appli-
cation of measurement normalization to our data could have
resulted in fewer discrepancies between devices, allowing
generalization of our findings across instruments. Indeed,
earlier studies have reported reduction in RNFL thickness
measurements between two different SD-OCT devices
following signal normalization.44–46
In conclusion, the number of steps to the average RNFL
floor is similar among the three devices despite differences in
residual layer thickness, RNFL dynamic range, and the amount
of relative VF sensitivity at which average RNFL reaches the
floor. The RNFL reaches the floor while more than 50% of
visual function remains.
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